Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

Blood Adv (2023) 7 (12): 2699–2708.

https://doi.org/10.1182/bloodadvances.2022009376

Published: 2023

Includes: Supplemental data

Journal Articles

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

Satoshi Nishiwaki, Yu Akahoshi, Mari Morita-Fujita, Hiroaki Shimizu, Naoyuki Uchida, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Kazuhiro Ikegame, Shuichi Ota, Yuta Katayama, Satoshi Takahashi, Toshiro Kawakita, Takahide Ara, Makoto Onizuka, Takafumi Kimura, Junji Tanaka, Yoshiko Atsuta, Yasuyuki Arai

Blood Adv (2022) 6 (15): 4558–4569.

https://doi.org/10.1182/bloodadvances.2022008032

Published: 2022

Includes: Supplemental data

Journal Articles

Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph + ALL during both CR1 and CR2

Satoshi Nishiwaki, Yu Akahoshi, Shuichi Mizuta, Akihito Shinohara, Shigeki Hirabayashi, Yuma Noguchi, Takahiro Fukuda, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Yukiyasu Ozawa, Shuichi Ota, Souichi Shiratori, Yasushi Onishi, Yoshinobu Kanda, Masashi Sawa, Junji Tanaka, Yoshiko Atsuta, Shinichi Kako

Blood Adv (2021) 5 (2): 584–592.

https://doi.org/10.1182/bloodadvances.2020003536

Published: 2021